Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration
Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the effectiveness of reactive focal drug administration
(RFDA) using dihydroartemisinin+piperaquine (DHAP) versus reactive focal test and treat
(RFTAT) using artemether+lumefantrine (AL) as a routine process for identifying and
eliminating malaria transmission as measured through achieving zero seropositivity in
children under five in Southern Province, Zambia. These two strategies are potential
candidates for expanded malaria operational surveillance and elimination for low malaria
transmission areas.